rfhg_92384.1

Basic information about the TSS

---

TSS ID: rfhg_92384.1 Species: human Chr: chr7		Start: 23505570 End: 23505586 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000475970.1:-299 GeneID: 29896 HGNC/MGI_ID: HGNC:16645 UniProt_ID: Nearer transcript ids and distances:

Gene_name: transformer 2 alpha homolog Gene_symbol: TRA2A Gene_synonyms: AWMS1 htra-2-alpha Gene_source: HGNC:16645

TATA-Box annotation

---

Distance to TSS:	15190
Nearest PromoterID:	NR_026676
Entrez ID:	256355
Nearest Unigene:	Hs.367935
Nearest Refseq:	NR_026676
Nearest Ensembl:	ENSG00000232818
Gene Name:	transformer 2 alpha homolog
Gene Alias:	RPS2_14_794
Gene Type:	pseudo
CpG%:	0.000000
GC%:	0.294118
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TRA2A p2@TRA2A p3@TRA2A p4@TRA2A
Sample		p1@TRA2A	p2@TRA2A	p3@TRA2A	p4@TRA2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	73.44	4.09	14.42	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.25	5.87	16.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	85.07	5.21	17.17	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	54.06	3.12	17.05	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	59.17	3.82	15.52	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	61.44	4.07	10.66	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	64.71	3.49	15.25	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	61.28	1.70	9.45	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	58.13	2.56	8.98	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	64.92	5.80	21.45	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	72.76	4.85	10.91	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	79.28	3.25	11.38	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.63	4.03	4.67	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.71	2.10	2.71	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.34	1.98	4.83	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.38	2.26	3.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.25	1.09	3.71	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.78	3.37	2.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	2.67	3.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.03	2.71	3.91	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	25.66	2.81	3.34	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	25.20	3.28	3.80	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	25.98	3.75	3.36	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	20.63	2.67	5.10	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.41	3.35	4.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.26	2.53	2.85	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.08	3.30	4.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.47	3.30	3.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.49	2.91	3.55	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.90	1.63	5.07	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.05	2.93	4.81	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.39	1.95	3.91	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.37	2.11	4.01	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.50	3.13	3.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.63	2.99	3.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.55	2.11	3.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.23	1.64	5.11	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.14	2.42	1.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.99	1.62	6.48	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.96	0.96	5.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.82	1.65	3.76	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.50	3.22	3.07	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.10	3.16	6.54	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	23.43	1.92	3.50	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.08	3.01	2.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.64	1.63	6.75	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.31	2.16	6.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.27	2.09	3.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	28.25	3.35	8.38	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.65	2.83	4.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	39.76	3.28	4.71	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.69	3.78	9.34	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	13.99	391.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	32.65	4.61	7.45	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	34.80	3.65	6.96	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	104.03	8.39	27.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	49.14	5.97	11.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	31.11	3.89	10.70	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.51	3.85	14.45	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	49.66	5.66	17.60	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	20.45	2.12	8.46	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	27.48	4.49	7.29	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	46.18	3.18	25.48	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	35.00	2.38	8.49	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	23.07	0.97	5.52	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	24.14	1.42	9.58	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	307.11	0.00	501.08	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	181.64	7.90	189.54	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	1.46	5.85	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.33	1.98	6.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	1.41	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.52	3.31	5.63	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.96	3.09	9.59	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.68	2.45	5.20	0.61
Adipocyte - breast, donor1	11376-118A8	27.72	4.91	5.54	0.16
Adipocyte - breast, donor2	11327-117E4	24.22	3.37	4.33	0.16
Adipocyte - omental, donor1	11473-119C6	27.99	4.07	6.11	0.13
Adipocyte - omental, donor2	11474-119C7	19.43	2.24	10.46	0.00
Adipocyte - omental, donor3	11475-119C8	19.09	2.68	4.02	0.00
Adipocyte - perirenal, donor1	11476-119C9	12.76	1.28	5.74	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.97	1.35	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.29	2.61	0.52	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	33.25	5.28	3.52	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	25.22	2.32	4.12	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	31.78	3.90	2.79	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	28.21	2.35	8.82	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	42.07	4.99	3.62	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	21.95	3.55	6.13	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	3.20	2.13	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	16.69	2.23	3.34	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	29.53	2.91	3.74	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	26.37	2.01	7.03	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	18.33	3.93	2.95	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.96	2.13	2.74	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	15.91	1.99	3.09	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	7.17	0.36	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.49	2.16	1.08	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	3.35	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.66	1.03	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	27.00	2.98	5.49	0.11
Anulus Pulposus Cell, donor2	11463-119B5	16.16	2.94	2.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.91	5.84	14.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.48	3.47	5.21	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	0.00	10.70	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	29.00	2.99	7.47	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	3.79	8.85	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	3.96	10.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.84	4.22	8.77	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	29.13	6.31	11.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.91	4.16	16.03	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	28.25	2.64	7.16	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	3.63	8.71	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	0.00	16.30	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	29.65	4.12	5.11	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	4.09	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.92	5.73	15.08	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.11	3.21	7.50	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.15	3.21	7.75	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.66	4.28	11.76	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	21.46	4.88	5.85	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.85	4.64	7.63	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	6.00	13.21	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	27.79	3.43	9.26	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	16.78	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	2.91	9.22	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	32.25	3.04	6.83	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	1.21	4.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.66	2.28	11.40	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.73	2.78	7.70	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.78	2.32	12.39	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	3.28	7.98	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.55	1.29	13.83	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	2.85	14.98	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	25.74	1.75	8.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	34.02	3.01	5.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	3.56	13.07	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	26.95	4.07	8.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	35.91	3.57	10.95	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	4.45	10.80	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	24.17	1.73	9.06	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.79	5.50	12.28	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.27	2.32	14.21	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	1.89	9.45	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	30.18	2.71	6.10	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	23.16	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	0.00	10.56	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.95	2.79	9.65	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	27.07	3.01	10.23	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.14	4.37	10.93	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.28	3.22	7.59	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	5.10	20.40	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.51	5.85	15.76	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	36.33	2.48	10.73	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	26.01	4.28	12.85	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	30.11	4.78	8.60	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	4.43	9.76	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	4.58	25.94	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.69	4.43	13.85	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.57	6.36	9.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.99	4.36	13.81	0.00
Astrocyte - cerebellum, donor1	11500-119F6	17.07	2.70	5.90	0.12
Astrocyte - cerebellum, donor2	11580-120F5	14.55	1.54	3.25	0.51
Astrocyte - cerebellum, donor3	11661-122F5	10.91	1.26	1.05	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	39.74	2.44	7.32	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	71.02	5.50	11.00	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	60.11	4.92	9.70	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	82.23	9.63	4.47	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	84.69	10.90	5.76	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	84.89	7.74	6.26	0.68
Basophils, donor1	12241-129G9	72.18	7.32	6.80	0.26
Basophils, donor2	12242-129H1	155.50	16.60	24.17	1.44
Basophils, donor3	12243-129H2	77.91	9.55	6.76	2.35
Bronchial Epithelial Cell, donor1	11511-119G8	2.80	0.43	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.18	1.88	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	15.60	2.29	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	9.67	1.84	1.61	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	14.04	1.80	1.08	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	104.70	9.07	28.96	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	99.22	9.78	13.97	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	114.48	15.67	15.03	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	117.22	8.45	19.72	3.38
CD14+ Monocytes, donor2	11305-117B9	116.19	11.88	10.58	2.41
CD14+ Monocytes, donor3	11381-118B4	118.33	11.42	21.51	4.17
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	32.27	2.26	5.09	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	38.67	4.93	5.69	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	37.81	3.29	0.99	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	73.29	6.50	5.93	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	67.89	4.83	6.34	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	79.60	5.45	6.16	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	76.00	4.85	8.20	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	97.43	3.59	7.18	4.69
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	114.54	5.95	8.43	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	102.99	4.90	14.88	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	96.15	5.88	6.94	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	139.07	8.49	10.01	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	105.12	6.56	13.11	3.75
CD14+ monocytes - treated with Candida, donor2	11878-125C6	147.32	8.98	12.67	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	135.34	4.44	17.75	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	71.25	5.21	8.78	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	77.82	4.99	3.99	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	114.09	8.95	5.20	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	107.99	8.47	11.67	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	100.66	4.75	4.52	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	110.42	7.42	7.86	4.80
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	66.44	6.99	9.15	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	96.65	7.15	10.64	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	107.73	4.21	11.78	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	98.47	5.14	11.76	2.02
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	115.54	4.23	5.64	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	133.81	6.14	10.53	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	91.02	5.75	14.30	4.71
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	90.69	4.46	17.10	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	131.70	8.84	6.04	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	80.26	6.14	12.69	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	102.22	5.79	5.56	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	125.51	8.82	10.44	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	61.68	8.28	7.41	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	66.30	10.16	8.55	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	55.89	8.45	3.68	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	80.66	12.77	11.21	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	54.31	10.30	12.57	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	96.77	14.49	6.02	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	54.86	13.01	7.14	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	64.55	10.32	7.47	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	61.90	6.95	7.16	1.89
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	146.33	26.42	14.23	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	151.19	19.66	9.49	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	162.59	14.50	11.39	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	136.46	22.92	20.79	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	154.92	27.88	9.11	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	138.28	21.06	14.04	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	117.65	18.82	16.47	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	166.10	21.09	7.91	0.00
CD19+ B Cells, donor1	11544-120B5	251.50	20.55	18.90	4.11
CD19+ B Cells, donor2	11624-122B4	236.49	20.31	26.12	5.80
CD19+ B Cells, donor3	11705-123B4	266.55	18.68	11.61	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	95.36	12.12	6.06	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	55.93	7.59	9.99	0.80
CD34+ Progenitors, donor1	11545-120B6	67.27	13.05	4.02	0.00
CD34+ Progenitors, donor2	11625-122B5	124.16	21.35	11.80	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	90.56	14.28	15.03	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	117.93	18.04	13.75	0.45
CD4+ T Cells, donor1	11225-116C1	210.66	26.78	26.07	6.78
CD4+ T Cells, donor2	11306-117C1	202.69	18.98	34.90	6.74
CD4+ T Cells, donor3	11382-118B5	156.16	14.33	30.50	7.62
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	77.08	16.85	3.83	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	80.18	14.60	20.89	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	77.90	17.25	7.76	2.30
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	181.58	34.61	11.38	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	162.24	28.09	17.56	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	108.78	23.07	23.07	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	75.87	14.74	11.85	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	73.04	15.76	30.67	2.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	66.09	14.35	15.48	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	121.49	23.76	23.31	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	117.39	19.57	12.23	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	147.83	30.80	6.16	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	79.69	20.66	12.23	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	64.62	10.39	32.62	3.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	63.82	11.03	20.05	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	148.75	22.84	19.31	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	178.47	24.12	16.61	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	168.56	16.14	10.76	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.91	13.35	12.61	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.22	13.21	18.63	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	81.33	13.66	12.19	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	131.96	17.70	8.60	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	139.07	16.03	12.13	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	183.04	18.74	7.84	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	180.13	34.15	15.84	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	148.63	20.31	10.16	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	160.52	23.73	9.77	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	167.26	36.28	4.43	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	172.26	33.13	7.12	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	113.96	38.50	10.78	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	176.55	28.29	9.31	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	204.98	36.01	13.85	0.00
CD8+ T Cells, donor1	11226-116C2	165.33	13.10	12.11	1.96
CD8+ T Cells, donor2	11307-117C2	168.57	13.52	20.27	5.26
CD8+ T Cells, donor3	11383-118B6	216.64	17.93	43.43	6.82
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.83	3.90	3.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.25	3.83	3.35	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.42	3.56	2.46	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.12	6.30	2.40	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.92	2.64	2.16	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.92	4.55	3.18	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.34	2.39	3.69	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.90	5.26	3.16	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.24	3.05	2.35	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.87	5.43	5.13	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.30	4.07	4.65	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	28.24	5.33	3.73	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	29.33	2.19	5.25	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.42	3.19	2.73	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	34.31	5.22	5.22	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.21	6.48	3.60	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	19.85	3.16	4.60	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.44	4.24	3.77	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.30	6.34	3.17	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.68	1.85	3.38	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.16	8.34	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	28.68	6.50	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.98	6.31	2.36	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	17.40	5.29	3.78	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	64.24	11.24	10.44	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	88.13	14.69	15.39	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	94.16	11.02	7.01	1.00
Cardiac Myocyte, donor1	11525-119I4	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	29.15	1.48	3.46	0.00
Cardiac Myocyte, donor3	11686-122I3	19.47	2.32	3.16	0.11
Chondrocyte - de diff, donor1	11261-116G1	27.39	4.16	6.59	1.04
Chondrocyte - de diff, donor2	11338-117F6	14.57	2.13	2.13	0.00
Chondrocyte - de diff, donor3	11410-118E6	25.15	4.10	3.87	0.23
Chondrocyte - re diff, donor2	11339-117F7	62.67	8.95	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	37.21	4.45	3.24	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	53.82	5.51	9.52	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	50.23	3.85	6.41	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	52.04	2.92	4.78	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.85	17.61	3.39	0.28
Corneal Epithelial Cells, donor1	11526-119I5	6.59	1.32	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.20	1.28	1.79	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	22.12	6.11	1.98	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.39	5.68	7.25	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	3.45	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.00	4.43	3.24	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	118.89	17.08	19.13	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	145.59	18.28	9.14	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	123.41	17.42	7.74	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	23.35	2.84	3.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	13.50	0.00	2.35	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	15.55	0.85	1.70	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	15.33	1.57	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	15.42	1.16	1.16	0.00
Endothelial Cells - Artery, donor2	11341-117F9	33.64	1.41	5.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	35.59	1.40	1.05	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	35.91	4.21	7.54	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	43.21	4.87	7.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	40.03	4.51	1.97	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	22.58	3.86	2.38	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	25.51	1.56	2.60	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.99	1.84	1.70	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	24.01	2.80	7.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	19.92	2.10	3.14	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	73.80	5.84	6.83	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.59	6.08	2.17	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	45.68	4.40	2.56	0.24
Endothelial Cells - Vein, donor1	11267-116G7	28.44	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.76	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.26	2.36	2.04	0.16
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	229.39	24.75	8.25	0.00
Eosinophils, donor3	12246-129H5	156.94	17.83	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.64	1.22	0.98	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	23.81	2.46	7.80	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.89	2.63	2.63	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.74	1.63	4.12	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	45.24	4.49	6.19	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	73.15	14.33	5.32	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.73	3.38	2.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	44.53	7.11	1.58	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	41.52	4.65	1.99	0.00
Fibroblast - Cardiac, donor1	11268-116G8	33.11	1.81	2.72	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.19	2.27	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.14	3.00	1.58	0.00
Fibroblast - Cardiac, donor4	11452-119A3	49.71	5.76	2.12	0.00
Fibroblast - Cardiac, donor5	11456-119A7	42.64	3.43	4.44	0.51
Fibroblast - Cardiac, donor6	11460-119B2	41.08	3.79	3.94	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.15	3.08	2.14	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.14	1.29	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	24.22	1.61	1.38	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	24.42	2.88	1.36	0.00
Fibroblast - Dermal, donor1	11269-116G9	23.48	4.46	2.35	0.00
Fibroblast - Dermal, donor2	11346-117G5	26.41	4.72	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	25.02	3.63	5.56	0.36
Fibroblast - Dermal, donor4	11450-119A1	43.75	4.86	4.63	0.34
Fibroblast - Dermal, donor5	11454-119A5	50.07	6.11	9.42	1.05
Fibroblast - Dermal, donor6	11458-119A9	62.37	6.98	12.83	0.32
Fibroblast - Gingival, donor1	11237-116D4	37.69	5.00	5.41	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	41.66	6.29	2.10	0.26
Fibroblast - Gingival, donor2	11318-117D4	53.77	3.95	9.88	0.53
Fibroblast - Gingival, donor3	11394-118C8	33.65	2.90	1.55	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	24.93	3.12	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.38	1.76	3.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.68	6.55	4.52	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.11	4.19	3.38	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	40.58	4.59	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.88	5.26	5.70	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.18	7.09	5.32	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	44.65	5.27	4.72	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.60	4.11	1.47	0.15
Fibroblast - Lung, donor1	11270-116H1	16.31	2.72	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	0.00	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	35.24	2.11	4.64	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	0.28	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	23.14	4.06	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	42.87	5.04	11.44	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	63.25	5.46	3.94	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	47.73	6.12	0.92	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.35	3.82	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.61	3.78	6.75	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.99	2.55	1.62	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	42.67	4.75	13.82	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.46	2.84	1.02	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.02	2.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	26.88	2.77	3.16	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	56.36	8.14	7.14	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	21.31	2.84	3.37	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	20.69	3.35	2.37	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	49.94	6.92	3.91	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.03	4.97	4.21	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	51.37	6.83	3.80	0.51
Fibroblast - skin normal, donor1	11553-120C5	22.48	3.45	1.97	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	85.02	15.44	8.62	0.60
Fibroblast - skin normal, donor2	11561-120D4	43.30	8.44	3.42	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	63.47	12.09	4.53	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	27.59	3.81	3.23	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.69	3.93	2.39	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	44.34	5.25	3.94	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	44.53	8.95	9.16	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	34.41	5.57	3.04	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.66	4.08	3.14	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	66.48	88.64	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	10.46	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	36.41	4.16	4.85	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	43.20	3.64	4.42	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	44.97	5.11	4.60	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	72.73	8.42	29.09	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	96.99	3.83	26.80	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	142.06	9.13	36.23	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	106.44	8.00	32.82	6.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	71.24	7.53	29.23	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	93.12	6.54	26.55	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	112.87	5.29	42.29	3.44
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	72.73	9.13	22.18	3.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	100.38	7.96	35.82	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	53.70	5.09	4.52	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	45.44	4.43	4.31	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	61.78	4.30	7.79	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.06	2.85	2.23	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.27	3.88	2.63	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	38.02	3.25	5.08	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	34.00	1.37	2.28	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	27.90	2.37	2.74	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	30.60	1.97	2.62	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	29.84	2.07	1.77	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.51	2.86	3.02	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	35.97	2.23	2.46	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	39.72	3.02	4.64	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	41.73	3.56	5.43	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.13	3.55	3.81	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.51	1.56	1.77	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.67	1.37	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	32.97	3.76	1.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.69	3.08	4.83	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.55	2.86	3.47	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.90	2.06	4.54	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	29.98	1.73	3.11	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.19	2.00	2.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.01	1.10	2.20	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	29.64	1.72	2.95	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	43.28	1.13	4.21	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	28.86	1.28	3.21	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.57	2.94	1.99	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	30.37	1.58	2.69	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	31.02	2.43	4.26	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.69	2.20	3.76	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	30.08	1.54	3.29	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.58	2.81	3.65	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.18	3.33	2.59	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.30	2.67	4.01	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.42	1.99	3.37	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.40	2.33	2.72	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	33.88	3.52	2.71	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	32.08	2.21	3.32	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.63	1.54	2.19	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	31.74	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.42	2.24	4.22	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.65	1.82	3.83	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	16.52	2.03	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	68.08	5.57	6.97	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	51.92	6.93	5.85	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	73.45	6.55	7.57	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	83.24	4.69	22.84	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	74.88	4.80	20.63	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	95.01	9.69	11.53	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	7.42	9.90	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	99.02	5.42	7.35	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	4.81	30.48	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	104.33	8.69	13.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	84.95	6.51	15.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	95.54	3.71	11.12	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	6.66	49.98	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	83.61	3.92	14.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	77.46	3.27	11.77	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	85.56	3.36	14.26	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	82.70	3.82	11.13	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	88.99	2.38	15.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	73.09	2.09	8.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	67.01	2.86	15.46	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	54.76	2.37	7.70	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	62.68	3.39	25.41	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	95.27	3.73	11.18	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	92.74	6.90	14.96	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	15.81	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	61.12	3.84	11.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	67.80	2.28	7.82	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.86	5.35	6.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	65.50	2.70	7.32	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	123.58	4.11	14.38	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	2.48	14.91	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	78.33	3.77	5.19	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	49.49	1.21	7.85	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	65.62	2.54	10.17	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	76.98	1.20	6.78	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	76.96	1.48	10.85	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	82.63	1.18	12.98	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	53.68	1.75	19.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	66.71	0.88	6.14	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	76.29	4.24	22.04	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.71	2.98	16.12	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	59.69	5.34	10.19	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	21.21	4.57	2.49	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	17.99	3.37	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	20.93	3.81	4.12	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.19	2.92	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	50.83	7.31	18.45	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	61.61	6.41	14.85	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	61.20	7.05	14.79	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	54.00	6.67	17.60	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	53.94	4.30	13.11	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	62.22	5.17	13.13	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.63	4.23	13.20	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	36.54	2.40	11.49	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	38.77	6.73	8.33	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.23	0.00	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	1.30	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	5.29	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.82	1.06	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	0.00	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	36.37	3.15	6.29	0.35
Hepatocyte, donor1	11523-119I2	32.69	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	24.78	4.31	4.31	2.15
Hepatocyte, donor3	11684-122I1	38.65	6.14	4.29	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	93.99	7.18	7.18	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	43.17	2.80	4.19	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	33.48	3.84	9.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	12.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	11.08	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	7.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	43.86	6.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	48.35	6.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	63.53	6.62	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	37.69	3.33	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	47.24	8.19	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	47.95	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	49.74	6.46	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	72.45	6.44	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	57.04	11.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	33.17	4.62	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	64.29	9.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	40.62	8.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	44.84	8.97	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	38.09	4.53	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	44.12	8.61	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	53.36	7.62	5.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	44.00	15.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	10.94	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	48.56	11.43	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	56.41	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	32.72	5.25	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	14.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	49.37	2.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	4.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	10.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	9.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	5.52	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	20.40	2.94	3.51	0.00
Keratinocyte - epidermal, donor2	11349-117G8	7.03	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	31.90	3.12	6.15	0.19
Keratinocyte - oral, donor1	11251-116E9	33.83	1.82	3.63	0.23
Keratocytes, donor1	11527-119I6	25.44	0.69	0.34	0.69
Keratocytes, donor2	11607-120I5	4.69	2.34	1.17	1.17
Keratocytes, donor3	11688-122I5	16.80	0.79	2.96	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	92.31	15.39	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	42.07	4.31	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	32.52	3.34	4.73	0.23
Lens Epithelial Cells, donor3	11690-122I7	20.69	2.83	1.72	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.22	3.20	3.68	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.30	0.84	5.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.95	3.62	11.65	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.43	1.08	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	13.24	2.84	4.73	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.50	1.40	6.04	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.09	4.10	5.34	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.61	2.02	1.77	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.71	1.69	4.22	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	0.40	3.96	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.39	1.55	4.65	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.33	0.74	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.56	1.74	3.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.74	2.39	3.34	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.44	1.79	4.40	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.25	2.16	4.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.22	0.62	3.74	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.67	1.10	4.03	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.48	1.32	6.25	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	1.76	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.45	1.24	2.74	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.34	1.94	5.33	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.54	1.89	5.12	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	19.07	2.88	6.21	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	2.59	3.63	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.05	1.68	2.93	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.23	1.95	4.81	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	21.32	2.75	4.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.43	1.13	5.08	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	13.89	0.74	3.92	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	1.45	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.59	1.32	2.98	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.02	1.36	3.84	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.88	3.70	5.18	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.07	1.98	2.96	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.41	1.10	2.61	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.44	2.57	6.43	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.69	2.43	4.26	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.53	2.80	5.32	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.89	1.78	2.49	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	0.97	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.20	0.78	2.02	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.56	1.79	4.30	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.49	2.29	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.18	1.88	3.53	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.81	2.35	2.72	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.66	0.51	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.02	0.60	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	4.53	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	4.60	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	4.45	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	27.08	4.65	4.65	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	34.46	4.22	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	3.74	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	34.01	3.61	3.09	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	34.49	3.57	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	38.00	5.88	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	33.45	4.36	8.72	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	50.87	5.40	8.55	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	40.37	6.10	1.63	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	3.08	6.16	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	36.34	5.65	3.18	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	36.65	3.33	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	33.62	3.57	8.15	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.69	6.94	3.47	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	45.35	2.27	6.42	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	34.36	5.52	4.91	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	45.66	4.89	4.89	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.23	6.04	5.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	32.51	5.04	9.81	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	2.06	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	37.74	9.29	3.77	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.99	4.78	8.97	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	30.98	3.32	2.77	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	33.58	6.01	3.89	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.08	5.90	6.27	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	37.99	6.91	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	36.46	4.61	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	30.00	6.23	5.10	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	30.36	4.10	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	32.54	5.42	2.71	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.03	5.03	7.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.08	3.73	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	30.84	4.83	2.60	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.00	4.31	5.17	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.96	2.57	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	34.65	2.67	3.66	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.34	3.62	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	4.27	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	33.68	3.44	4.47	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.91	0.54	4.29	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	27.61	4.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.89	2.96	4.82	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	9.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.21	7.60	2.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	5.09	4.36	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	3.07	4.60	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	45.38	5.43	6.41	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	27.29	8.47	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	43.24	5.53	3.52	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	40.11	7.66	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	8.61	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	40.08	4.45	3.56	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.83	3.52	4.30	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.07	3.96	4.62	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	45.15	3.63	4.67	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	46.38	5.25	4.81	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	29.63	5.03	6.15	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	32.68	5.74	6.18	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.80	6.56	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.87	5.06	5.06	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	45.18	3.36	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.97	5.17	2.78	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	29.17	3.65	3.65	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.98	5.53	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.84	4.94	5.32	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	4.13	5.16	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	25.40	1.21	3.02	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	37.39	4.12	4.44	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	31.99	6.93	5.33	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.01	5.17	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	36.51	4.11	4.11	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	35.37	4.24	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	29.51	3.40	3.40	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.94	4.58	3.74	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.19	3.13	3.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.05	5.43	4.18	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	43.21	3.25	5.58	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	8.70	4.68	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	31.54	2.67	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	48.49	4.45	3.64	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	30.29	3.67	5.51	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	1.78	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	51.29	6.27	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	2.30	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	28.45	2.74	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	32.96	3.56	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.69	4.42	2.34	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	27.85	1.33	5.30	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	4.16	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	23.25	3.19	5.47	0.46
Macrophage - monocyte derived, donor2	11313-117C8	16.15	4.77	2.75	0.18
Macrophage - monocyte derived, donor3	11389-118C3	23.86	2.88	3.80	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	35.58	6.90	3.19	0.00
Mallassez-derived cells, donor2	11929-125I3	47.54	4.44	3.01	0.00
Mallassez-derived cells, donor3	11930-125I4	41.56	5.28	4.73	0.00
Mammary Epithelial Cell, donor1	11273-116H4	42.75	5.08	7.87	0.30
Mammary Epithelial Cell, donor2	11350-117G9	24.32	3.76	2.90	0.00
Mammary Epithelial Cell, donor3	11422-118F9	9.98	2.00	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	116.61	12.88	2.71	0.00
Mast cell, donor1	11563-120D6	33.85	9.08	4.54	0.87
Mast cell, donor2	11565-120D8	90.04	20.21	2.08	1.19
Mast cell, donor3	11566-120D9	94.10	18.91	4.05	0.68
Mast cell, donor4	11567-120E1	82.26	16.13	3.55	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	41.47	11.87	3.22	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	27.43	10.51	10.51	1.17
Mast cell, expanded, donor5	11939-126A4	40.38	10.44	4.13	0.23
Mast cell, expanded, donor8	11941-126A6	37.16	8.70	9.21	0.17
Melanocyte - dark, donor1	11502-119F8	34.82	2.69	7.36	0.00
Melanocyte - dark, donor2	11582-120F7	30.46	2.08	2.77	0.35
Melanocyte - dark, donor3	11663-122F7	24.12	3.84	6.09	0.07
Melanocyte - light, donor1	11274-116H5	7.99	0.94	0.47	0.24
Melanocyte - light, donor2	11351-117H1	6.82	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	6.07	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	26.45	1.67	3.02	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	17.75	2.15	6.19	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	26.79	1.87	1.07	0.00
Meningeal Cells, donor1	11493-119E8	24.19	3.60	2.98	0.12
Meningeal Cells, donor2	11573-120E7	28.17	1.76	2.64	0.44
Meningeal Cells, donor3	11654-122E7	42.46	4.73	10.92	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	44.20	6.84	19.39	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	24.25	5.84	3.42	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	32.29	3.59	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	19.27	2.75	3.39	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.63	4.52	4.52	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.84	1.76	1.54	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	15.34	2.92	2.92	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.66	2.05	1.23	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.51	2.77	2.49	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.23	0.74	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.10	3.03	4.34	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.23	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	1.92	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.99	6.03	7.09	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.96	1.88	3.75	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.09	5.81	9.43	0.00
Mesothelial Cells, donor1	11247-116E5	37.12	5.30	5.57	0.00
Mesothelial Cells, donor2	12156-128G5	38.04	3.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	27.68	3.11	2.17	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	0.00	4.05	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	19.70	3.94	3.45	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.13	4.42	2.65	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	21.70	4.65	3.72	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	15.97	3.94	2.90	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.28	3.50	2.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	1.86	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.10	3.45	6.10	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.07	5.15	2.38	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	1.77	4.42	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.76	3.80	5.70	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.43	2.55	4.03	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	1.79	1.49	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.33	2.76	7.28	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.87	3.80	3.09	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	0.55	1.11	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	33.62	1.84	3.91	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.77	3.37	2.94	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.98	3.06	2.24	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	29.82	4.08	5.15	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	22.67	3.11	2.45	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	35.26	4.38	5.04	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	1.52	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.52	2.72	6.25	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.70	4.12	1.76	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	51.90	3.36	10.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	39.22	4.80	7.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	2.74	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	49.56	6.01	11.01	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	37.66	3.94	10.51	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	2.21	2.21	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	5.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	44.63	1.98	8.43	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	2.09	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	3.08	5.81	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	1.75	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.59	1.07	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.42	4.77	7.57	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.55	3.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.62	1.21	4.52	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.12	5.01	2.50	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	27.71	2.77	3.69	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.31	1.93	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	28.77	1.81	7.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.16	2.57	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	1.91	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.42	2.94	3.74	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	20.95	2.69	2.10	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.69	1.41	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	24.21	1.91	6.69	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	22.56	3.10	2.43	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.41	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	29.55	3.41	6.53	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.71	4.92	3.44	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	1.96	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.82	1.76	2.35	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.35	3.75	2.31	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.61	6.18	4.12	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.61	0.89	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	3.77	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.29	3.29	10.84	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	22.09	0.00	4.21	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.95	4.35	7.31	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	1.86	4.66	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	5.26	6.76	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.51	2.40	3.20	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.00	2.71	2.04	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	2.95	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.89	2.56	7.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	1.56	10.89	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	40.08	2.67	4.28	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	11.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	2.02	9.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	2.11	3.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	89.89	5.45	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	45.78	5.09	2.54	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	71.27	6.48	9.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	55.89	6.04	4.53	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	256.96	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	440.43	39.15	22.84	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	90.30	9.50	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	50.20	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.64	3.88	3.66	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	23.52	2.61	3.66	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	19.36	4.00	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.53	0.42	3.34	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	49.82	6.65	6.27	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	31.92	3.19	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	1.36	6.12	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	101.07	16.54	34.92	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.67	2.93	3.77	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.01	2.56	5.81	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.89	4.32	1.62	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.86	4.20	3.99	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	11.13	122.48	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.37	3.47	3.47	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.35	2.44	2.44	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.23	3.85	4.76	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.61	2.78	2.61	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.43	2.55	3.10	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	20.69	2.12	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.01	1.80	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.40	5.91	3.61	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.03	3.09	1.63	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.40	3.00	2.12	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	1.41	4.92	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.33	3.22	3.22	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.53	3.53	2.89	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	42.08	4.83	12.42	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	101.14	12.64	15.17	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.60	1.78	1.34	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	3.39	2.12	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.38	3.56	5.22	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.03	4.29	2.58	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	18.06	108.33	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.00	1.67	2.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	0.45	1.80	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.27	3.17	3.17	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	29.72	1.86	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	3.41	5.68	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	2.61	1.96	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	3.49	2.61	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.52	1.81	2.71	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	4.41	4.41	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	1.99	3.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	0.99	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	1.91	1.53	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.73	6.35	6.65	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.90	3.76	2.65	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	2.03	3.39	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	15.33	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	3.05	4.27	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.65	3.15	2.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.32	3.03	5.45	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	0.00	4.75	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	37.41	3.40	14.74	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	0.00	40.46	0.00
Myoblast, donor1	11241-116D8	36.15	7.58	5.84	0.37
Myoblast, donor2	11322-117D8	34.52	5.95	3.07	0.19
Myoblast, donor3	11398-118D3	33.46	6.22	3.87	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	45.53	4.96	5.11	0.73
Natural Killer Cells, donor1	11230-116C6	170.98	19.07	16.61	1.23
Natural Killer Cells, donor2	11311-117C6	164.35	14.47	24.12	6.33
Natural Killer Cells, donor3	11387-118C1	169.51	12.15	30.92	6.26
Neural stem cells, donor1	11275-116H6	64.97	6.53	0.00	0.00
Neural stem cells, donor2	11352-117H2	121.32	11.55	1.93	0.00
Neurons, donor1	11494-119E9	95.58	17.07	1.14	1.14
Neurons, donor2	11574-120E8	68.47	11.23	10.13	0.22
Neurons, donor3	11655-122E8	108.53	13.98	14.80	1.64
Neutrophils, donor1	11233-116C9	165.18	20.42	12.06	0.93
Neutrophils, donor2	11314-117C9	98.56	14.49	8.70	2.90
Neutrophils, donor3	11390-118C4	236.40	29.93	4.28	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	19.59	3.32	1.54	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	1.30	3.91	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	17.65	1.60	4.21	0.00
Olfactory epithelial cells, donor1	11933-125I7	22.30	5.51	13.63	0.14
Olfactory epithelial cells, donor2	11934-125I8	35.61	4.63	9.70	0.58
Olfactory epithelial cells, donor3	11935-125I9	30.76	3.97	19.98	0.34
Olfactory epithelial cells, donor4	11936-126A1	22.60	3.31	3.80	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	39.12	1.81	4.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	17.87	2.34	3.40	0.21
Osteoblast - differentiated, donor2	11353-117H3	2.29	1.14	3.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.76	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	25.60	3.52	4.10	0.00
Osteoblast, donor2	11354-117H4	36.52	2.81	5.62	0.70
Osteoblast, donor3	11426-118G4	26.84	4.09	1.07	0.00
Pancreatic stromal cells, donor1	11249-116E7	42.12	5.64	5.22	0.25
Pericytes, donor1	11491-119E6	5.23	1.11	0.67	0.11
Pericytes, donor2	11571-120E5	7.47	1.81	0.23	0.23
Pericytes, donor3	11652-122E5	16.89	2.03	2.03	0.00
Perineurial Cells, donor1	11499-119F5	30.63	3.84	9.83	0.11
Perineurial Cells, donor2	11579-120F4	37.63	3.50	3.04	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	113.47	17.21	7.65	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	111.66	16.41	14.20	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	101.07	10.74	4.40	1.68
Placental Epithelial Cells, donor1	11278-116H9	25.11	2.63	5.02	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.12	1.37	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.04	2.85	3.80	0.00
Preadipocyte - breast, donor1	11467-119B9	21.20	3.94	3.94	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	56.39	7.44	6.00	0.39
Preadipocyte - breast, donor2	11328-117E5	24.99	3.60	3.15	0.00
Preadipocyte - omental, donor1	11468-119C1	23.66	5.33	2.66	0.11
Preadipocyte - omental, donor2	11329-117E6	29.68	5.24	5.67	0.00
Preadipocyte - omental, donor3	11403-118D8	30.23	5.73	5.01	0.29
Preadipocyte - perirenal, donor1	11469-119C2	11.81	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	17.51	3.38	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	67.29	10.80	8.32	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	35.93	5.79	5.62	0.17
Preadipocyte - visceral, donor1	11280-116I2	47.60	8.20	5.68	0.19
Preadipocyte - visceral, donor2	11357-117H7	40.96	5.98	7.36	0.00
Preadipocyte - visceral, donor3	11429-118G7	43.89	4.39	7.52	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	40.88	1.96	2.72	0.30
Prostate Epithelial Cells, donor2	11331-117E8	34.40	3.39	3.66	0.00
Prostate Epithelial Cells, donor3	11404-118D9	17.33	1.59	1.53	0.12
Prostate Stromal Cells, donor1	11254-116F3	35.42	6.26	7.75	0.00
Prostate Stromal Cells, donor2	11332-117E9	38.01	6.81	7.17	0.36
Prostate Stromal Cells, donor3	11405-118E1	30.87	4.59	10.64	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.66	0.73	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.67	2.43	6.31	0.49
Renal Epithelial Cells, donor1	11517-119H5	7.10	2.03	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	9.96	0.71	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	27.63	2.12	5.08	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.15	1.62	2.56	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.75	2.89	3.55	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	1.33	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.36	1.54	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	6.90	0.00	1.88	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.16	1.39	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	3.76	1.61	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	0.42	2.11	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.23	1.16	2.31	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.89	2.33	8.30	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.35	1.14	1.42	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	1.76	4.27	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	55.73	5.21	6.15	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	44.67	2.68	4.47	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	95.21	2.20	3.30	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	70.19	1.74	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	58.38	5.33	5.59	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	52.23	4.47	6.16	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	64.80	4.80	8.03	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	91.42	6.45	6.82	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	69.34	5.71	6.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	96.15	4.85	7.86	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	42.17	3.01	5.48	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	65.35	4.54	5.45	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	61.82	5.73	11.83	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	46.91	3.30	5.16	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	58.81	5.26	9.23	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	80.54	6.20	7.97	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	32.69	2.68	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	53.76	4.56	5.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	68.02	6.01	6.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.42	3.85	2.65	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	59.28	3.60	4.38	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	64.74	7.83	8.21	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	41.97	3.31	2.03	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	52.70	2.24	4.20	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	66.31	4.27	6.15	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.20	3.65	2.37	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	53.84	4.91	5.27	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	74.01	4.30	6.58	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	44.58	4.01	6.13	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	52.58	5.75	5.75	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	75.53	5.85	9.12	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	55.16	5.60	4.56	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	50.44	4.20	3.76	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	59.53	5.01	3.97	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	49.39	5.38	5.79	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	39.34	5.11	3.07	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	73.07	5.59	7.71	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	57.94	5.50	4.13	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	43.07	3.84	4.39	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	79.46	5.25	6.90	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	39.71	2.56	4.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.07	2.96	4.59	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	63.71	5.06	4.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	37.33	1.80	3.04	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	64.76	5.24	8.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	76.99	4.64	2.62	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.20	2.73	3.01	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	60.09	3.84	4.19	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	50.77	3.02	3.63	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.73	3.06	4.53	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	117.17	6.99	10.48	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	89.44	3.04	5.48	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	49.43	2.71	3.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	57.23	5.43	4.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	72.79	3.59	5.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	46.05	2.83	4.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.76	2.77	2.77	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	70.31	3.00	5.41	1.20
Schwann Cells, donor1	11498-119F4	8.46	1.50	0.94	0.00
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	34.83	4.82	5.48	0.66
Sebocyte, donor1	11220-116B5	37.25	4.93	3.29	0.00
Sebocyte, donor2	11301-117B5	30.79	4.14	0.92	0.00
Sebocyte, donor3	11378-118B1	14.22	1.65	0.62	0.21
Sertoli Cells, donor1	11255-116F4	31.48	1.66	6.63	0.00
Sertoli Cells, donor2	11333-117F1	33.89	8.47	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	18.65	2.73	3.70	0.18
Skeletal Muscle Cells, donor2	11358-117H8	11.57	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.06	5.02	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	33.93	5.50	15.40	0.31
Skeletal Muscle Cells, donor5	11455-119A6	36.12	3.42	17.54	0.74
Skeletal Muscle Cells, donor6	11459-119B1	42.63	5.54	9.08	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	40.95	5.67	7.06	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	35.24	4.71	6.42	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	51.49	5.36	3.37	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.60	3.54	3.79	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.23	3.62	5.07	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.37	2.89	2.48	0.28
Skin - palm, donor1	10286-104F7	56.41	10.74	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.97	1.30	1.73	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	151.31	16.36	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.76	2.08	2.73	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	24.19	3.06	4.03	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	26.16	2.39	3.09	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	127.08	16.49	7.19	3.59
Small Airway Epithelial Cells, donor3	11406-118E2	23.91	1.80	1.50	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.06	4.01	2.16	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	39.35	3.56	2.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	2.94	4.11	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	33.37	2.65	4.42	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.02	3.15	3.94	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	31.68	3.86	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	26.02	4.00	4.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	30.74	3.86	3.19	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	36.13	6.43	6.21	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	29.19	4.48	1.79	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.28	6.51	6.51	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	37.51	4.43	5.32	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.63	2.28	2.85	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.55	1.30	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.96	0.61	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.94	3.79	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.50	1.43	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	23.45	3.98	6.05	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.84	3.44	3.66	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	36.74	3.04	4.51	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.13	4.95	3.87	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.92	5.08	5.08	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.58	1.71	1.71	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.08	3.77	6.36	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	38.85	7.35	3.52	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	34.82	1.82	8.65	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	1.21	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	72.32	8.21	9.01	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.83	7.19	5.86	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.93	6.01	5.01	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.77	4.57	1.78	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.80	5.43	5.43	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.75	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	90.46	5.17	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	21.86	2.79	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	25.24	6.06	6.06	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.21	2.51	2.82	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	2.36	1.77	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.07	8.00	10.16	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.76	3.27	2.80	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.90	3.60	2.16	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	32.12	5.35	7.14	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.73	1.88	1.13	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	40.25	5.73	5.73	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	21.11	2.68	2.77	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	20.55	1.47	3.18	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.35	7.73	11.49	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	30.72	5.27	4.39	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.21	2.33	2.72	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.16	3.17	1.85	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.26	4.84	6.70	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.15	3.95	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.27	2.84	3.69	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.17	4.33	2.76	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	31.24	3.81	3.05	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	2.00	4.39	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	21.74	3.76	5.85	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	29.79	1.83	6.88	0.46
Synoviocyte, donor1	11291-117A4	38.04	2.69	4.88	0.17
Synoviocyte, donor2	11368-117I9	25.65	4.19	4.36	0.84
Synoviocyte, donor3	11440-118H9	20.33	2.46	1.56	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	1.07	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	17.37	1.85	1.62	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	18.35	2.94	2.65	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	2.71	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	56.96	6.15	5.54	1.23
Urethra, donor2	10319-105A4	52.15	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	4.52	0.27	0.53	0.27
Urothelial Cells, donor2	11600-120H7	8.01	2.00	1.20	0.40
Urothelial Cells, donor3	11681-122H7	4.81	1.15	0.23	0.00
Urothelial cells, donor0	11216-116B1	17.83	2.45	2.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	80.97	18.69	17.80	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	54.33	18.58	12.87	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	59.55	15.06	11.64	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	70.93	9.30	9.30	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	62.17	12.20	10.46	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	53.10	12.49	10.41	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	73.42	21.11	12.85	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	57.51	6.39	14.61	0.00
Wilms' tumor cell line:G-401	10809-111A8	77.22	7.03	8.64	0.62
Wilms' tumor cell line:HFWT	10597-108E3	22.88	3.52	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	78.77	4.47	11.45	1.12
achilles tendon, donor2	10292-104G4	53.73	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	91.78	6.37	14.53	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	124.68	10.91	15.79	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	152.06	9.62	16.98	4.27
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	102.59	9.52	11.43	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	38.79	8.15	10.12	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	43.78	8.25	2.75	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	22.05	2.72	2.99	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	85.92	11.02	19.39	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	46.96	5.72	5.31	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	71.06	10.48	12.43	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	35.70	5.89	4.60	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	73.90	11.85	6.74	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	71.46	11.39	9.06	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	52.60	6.43	4.97	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	41.83	6.97	4.18	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.26	2.06	2.06	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	20.26	3.68	3.38	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	50.78	10.67	3.41	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	43.67	8.80	4.25	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	69.08	16.85	6.74	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	52.12	10.91	13.36	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	34.36	3.00	4.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	13.01	3.72	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	82.87	9.79	13.94	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	66.29	8.72	6.11	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	3.75	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	77.01	7.30	3.53	0.71
adipose tissue, adult, pool1	10010-101C1	31.64	5.12	2.17	0.00
adipose, donor1	10184-103D4	257.43	12.31	56.88	2.35
adipose, donor2	10185-103D5	38.12	5.68	25.14	2.84
adipose, donor3	10186-103D6	71.61	5.72	20.15	1.91
adipose, donor4	10187-103D7	87.54	6.07	40.74	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	39.46	6.47	2.05	0.32
adrenal gland, adult, pool1	10081-102A9	36.38	18.19	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	29.22	3.74	2.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	61.81	10.36	15.36	0.71
amniotic membrane cells, donor1	12235-129G3	45.67	5.56	3.71	0.46
amniotic membrane cells, donor2	12236-129G4	30.43	3.04	2.03	1.01
amniotic membrane cells, donor3	12237-129G5	50.97	3.83	2.36	1.18
amygdala - adult, donor10196	10167-103B5	42.69	7.11	7.11	0.00
amygdala, adult, donor10252	10151-102I7	67.12	8.11	2.84	0.81
amygdala, newborn, donor10223	10360-105E9	44.54	11.62	8.07	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	15.28	1.40	2.04	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	57.14	8.60	12.35	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	100.21	12.36	19.71	10.69
aorta, adult, pool1	10052-101G7	50.41	5.88	2.35	1.37
appendix, adult	10189-103D9	75.29	10.09	5.43	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	79.79	9.63	8.60	2.41
artery, adult	10190-103E1	39.40	6.79	4.08	2.72
astrocytoma cell line:TM-31	10425-106D2	61.71	7.68	8.55	0.72
b cell line:RPMI1788	10427-106D4	52.05	9.37	4.46	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	55.77	6.66	8.05	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	59.94	8.63	6.55	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	21.76	1.67	3.85	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	39.15	6.15	18.45	1.12
bladder, adult, pool1	10011-101C2	45.30	6.41	5.43	0.54
blood, adult, pool1	10053-101G8	64.22	2.21	6.64	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	7.71	3.43	0.00
bone marrow, adult	10192-103E3	43.19	5.40	2.70	0.00
brain, adult, donor1	10084-102B3	31.78	11.28	2.05	0.00
brain, adult, pool1	10012-101C3	30.62	7.35	1.34	0.00
brain, fetal, pool1	10085-102B4	40.07	13.36	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	66.07	4.96	2.97	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	43.44	6.99	3.87	0.62
breast, adult, donor1	10080-102A8	41.67	4.42	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	54.37	14.61	6.10	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	43.60	9.59	5.88	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	82.65	12.20	14.27	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	54.71	7.26	6.05	2.91
carcinoid cell line:NCI-H1770	10703-109H1	70.53	5.64	16.46	2.82
carcinoid cell line:NCI-H727	10735-110B6	44.96	3.17	2.08	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	75.10	7.29	16.48	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	104.34	17.57	9.85	1.86
caudate nucleus - adult, donor10196	10177-103C6	59.87	8.06	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	65.26	9.04	3.51	0.84
caudate nucleus, adult, donor10258	10379-105H1	29.80	11.46	6.11	0.76
caudate nucleus, newborn, donor10223	10354-105E3	70.68	12.45	7.69	0.37
cerebellum - adult, donor10196	10173-103C2	110.70	20.39	11.65	2.91
cerebellum, adult, donor10252	10166-103B4	127.68	22.42	5.55	1.07
cerebellum, adult, pool1	10083-102B2	43.46	10.00	6.21	2.07
cerebellum, newborn, donor10223	10357-105E6	113.75	20.76	3.32	3.32
cerebral meninges, adult	10188-103D8	28.49	8.07	9.58	0.76
cerebrospinal fluid, donor2	10294-104G6	24.85	1.46	3.65	1.46
cervical cancer cell line:D98-AH2	10552-107I3	44.28	6.04	5.75	0.00
cervical cancer cell line:ME-180	10553-107I4	66.95	3.15	18.06	1.16
cervix, adult, pool1	10013-101C4	70.76	11.76	14.07	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.47	4.46	6.41	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	3.92	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	56.79	4.97	6.09	0.25
choriocarcinoma cell line:SCH	10785-110H2	68.14	3.20	7.15	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	63.33	6.64	5.69	0.47
chorionic membrane cells, donor1	12238-129G6	40.17	4.27	4.56	0.28
chorionic membrane cells, donor2	12239-129G7	32.61	1.89	2.59	0.00
chorionic membrane cells, donor3	12240-129G8	62.09	3.30	3.30	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	64.63	7.07	15.15	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	51.10	7.11	5.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	41.39	7.60	3.80	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	51.62	6.68	3.34	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.84	7.50	3.63	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	63.93	6.11	1.22	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	69.20	14.72	13.25	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	60.20	11.21	5.21	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	45.72	4.57	7.54	1.37
clear cell carcinoma cell line:TEN	10636-108I6	97.86	5.38	7.98	1.56
colon carcinoma cell line:CACO-2	10513-107D9	78.16	5.49	11.35	1.10
colon carcinoma cell line:COLO-320	10420-106C6	49.41	6.46	1.52	0.38
colon, adult, donor1	10082-102B1	47.60	5.95	3.57	0.00
colon, adult, pool1	10014-101C5	39.72	5.29	6.82	0.47
colon, fetal, donor1	10070-101I7	58.71	9.27	9.27	3.09
common myeloid progenitor CMP, donor1	12130-128D6	119.17	22.92	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	109.63	25.92	19.55	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	47.39	8.60	7.24	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	55.84	12.55	9.02	0.71
corpus callosum, adult, pool1	10042-101F6	79.16	11.17	4.64	0.33
cruciate ligament, donor2	10295-104G7	41.33	9.73	1.62	2.43
diaphragm, fetal, donor1	10069-101I6	56.98	4.82	2.41	2.41
diencephalon, adult	10193-103E4	35.52	6.48	2.40	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	137.08	10.10	16.07	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	50.78	8.72	6.92	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	56.33	8.67	20.70	1.93
ductus deferens, adult	10196-103E7	69.27	5.98	7.97	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	61.93	10.08	7.20	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	78.71	9.56	5.15	1.47
dura mater, adult, donor1	10041-101F5	46.41	7.68	1.73	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	93.05	7.11	10.22	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	85.98	6.88	29.81	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	48.71	4.93	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	33.00	4.24	2.72	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	54.96	4.94	2.16	0.00
embryonic pancreas cell line:2C6	10603-108E9	49.91	5.25	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	43.91	4.69	6.37	3.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	34.98	4.89	6.89	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	64.33	3.22	4.99	0.16
epidermoid carcinoma cell line:A431	10426-106D3	54.36	4.89	6.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	50.04	6.60	4.29	0.11
epididymis, adult	10197-103E8	45.42	7.33	5.23	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	34.59	9.05	5.14	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.78	4.33	3.54	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	59.37	5.24	10.48	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	70.86	6.00	8.37	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.33	5.83	12.32	0.22
esophagus, adult, pool1	10015-101C6	40.67	5.31	3.82	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	70.38	8.89	4.76	0.25
eye - muscle inferior rectus, donor1	10272-104E2	38.63	4.83	2.41	4.83
eye - muscle lateral, donor2	10298-104H1	27.35	4.21	4.21	0.00
eye - muscle medial, donor2	10299-104H2	17.86	7.44	1.49	2.98
eye - muscle superior, donor2	10297-104G9	27.52	5.73	6.88	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	4.37	7.29	0.00
eye, fetal, donor1	10054-101G9	57.46	9.15	5.08	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	25.13	3.46	2.95	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	51.52	6.65	14.96	0.00
frontal lobe, adult, pool1	10040-101F4	45.97	15.20	3.66	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	53.44	6.00	9.61	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	60.99	4.75	6.03	1.10
gall bladder, adult	10198-103E9	36.46	3.14	2.90	0.24
gamma delta positive T cells, donor1	11937-126A2	113.81	19.33	17.18	1.61
gamma delta positive T cells, donor2	11938-126A3	104.20	16.06	13.07	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.75	2.75	4.01	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	72.14	10.83	2.32	0.77
gastric cancer cell line:AZ521	10549-107H9	41.15	8.69	15.58	1.97
gastric cancer cell line:GSS	10560-108A2	62.24	5.49	6.41	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	126.34	2.28	6.17	1.83
giant cell carcinoma cell line:LU65	10487-107B1	23.64	4.13	4.02	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	99.93	16.94	9.80	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	35.17	5.74	5.49	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	46.65	7.18	6.86	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.19	8.29	5.90	0.98
glioblastoma cell line:T98G	10485-107A8	55.96	7.40	10.15	1.99
glioma cell line:GI-1	10413-106B8	52.72	9.96	5.56	0.59
globus pallidus - adult, donor10196	10175-103C4	53.94	5.83	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	114.24	12.45	7.81	2.44
globus pallidus, adult, donor10258	10367-105F7	62.98	10.95	23.28	10.95
globus pallidus, newborn, donor10223	10364-105F4	43.70	3.20	3.73	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	80.76	26.92	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	38.72	4.48	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	61.06	5.05	5.05	0.92
hIPS +CCl2, biol_rep2	14384-156C1	50.30	3.20	3.66	0.91
hIPS +CCl2, biol_rep3	14385-156C2	65.70	10.31	8.37	1.29
hIPS, biol_rep1	14380-156B6	61.80	7.19	12.94	0.00
hIPS, biol_rep2	14381-156B7	52.13	5.49	14.40	0.00
hIPS, biol_rep3	14382-156B8	38.62	5.52	5.52	1.10
hairy cell leukemia cell line:Mo	10712-109I1	42.81	7.18	10.34	0.57
heart - mitral valve, adult	10205-103F7	56.50	4.78	4.78	1.20
heart - pulmonic valve, adult	10206-103F8	32.42	7.32	3.40	0.78
heart - tricuspid valve, adult	10207-103F9	39.13	4.16	5.83	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	40.20	2.86	3.67	1.22
heart, adult, diseased, donor1	10051-101G6	17.46	1.70	2.13	0.43
heart, adult, pool1	10016-101C7	15.41	2.07	6.21	0.00
heart, fetal, pool1	10046-101G1	70.95	6.67	3.59	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	31.16	4.32	4.63	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	60.65	5.95	5.95	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	74.47	3.20	5.52	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	86.78	4.49	6.07	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	78.82	4.85	5.76	1.01
hepatoma cell line:Li-7	10484-107A7	33.70	1.56	5.45	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	47.84	5.33	3.32	0.10
hippocampus - adult, donor10196	10169-103B7	44.48	9.46	7.57	1.89
hippocampus, adult, donor10252	10153-102I9	73.48	8.98	4.90	0.61
hippocampus, adult, donor10258	10374-105G5	29.38	6.97	2.99	0.50
hippocampus, newborn, donor10223	10363-105F3	32.08	9.52	4.58	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	153.20	6.71	34.18	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	76.58	4.91	15.71	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	78.96	3.81	15.49	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	73.30	5.64	20.30	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	101.99	5.42	18.59	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	92.25	5.31	23.16	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	94.59	7.01	9.34	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	82.51	5.39	16.37	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	61.31	8.76	13.35	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	74.12	9.47	9.47	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	64.93	8.20	14.95	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	78.10	11.45	13.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	70.11	3.76	15.96	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	92.36	1.97	15.72	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	107.35	5.24	21.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	81.71	6.49	17.56	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	73.70	4.36	15.70	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	130.44	4.00	24.99	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	61.04	6.78	8.29	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	63.21	6.37	11.37	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	52.31	7.83	15.66	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	52.58	4.25	12.41	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	56.32	4.06	13.06	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	50.82	4.78	12.26	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	108.63	7.94	32.15	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	106.98	6.28	32.52	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	134.74	7.76	51.04	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	102.81	7.39	16.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	73.80	7.29	25.02	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	69.30	6.66	23.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	61.54	5.69	17.07	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	56.45	4.65	14.61	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	57.21	3.85	6.93	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	69.28	5.37	12.78	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	66.64	6.06	17.42	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	57.47	5.04	25.88	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	97.81	7.97	33.09	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	121.22	7.13	42.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	104.39	4.88	40.98	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	82.52	6.42	22.62	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	692.94	39.04	126.88	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	124.43	6.29	32.76	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.45	6.57	19.70	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	57.90	4.70	14.11	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	54.45	3.91	14.59	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	41.77	4.77	16.71	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	75.57	8.67	9.34	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	49.30	3.77	29.36	1.08
immature langerhans cells, donor1	11904-125F5	112.60	12.59	4.60	1.70
immature langerhans cells, donor2	11905-125F6	170.31	11.09	14.26	7.13
insula, adult, pool1	10039-101F3	48.93	17.03	2.46	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	33.49	5.85	3.90	0.33
kidney, adult, pool1	10017-101C8	38.35	4.71	4.31	0.10
kidney, fetal, pool1	10045-101F9	53.41	6.44	1.34	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	62.92	7.10	5.96	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.15	2.07	1.80	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	44.59	4.77	4.59	0.55
left atrium, adult, donor1	10079-102A7	25.06	1.63	3.27	0.00
left ventricle, adult, donor1	10078-102A6	16.69	1.52	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	57.46	11.22	7.39	1.92
leiomyoma cell line:10964C	10569-108B2	25.87	2.87	3.23	0.00
leiomyoma cell line:15242A	10570-108B3	31.52	3.80	8.70	0.00
leiomyoma cell line:15425	10571-108B4	31.32	7.04	8.01	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	38.69	8.36	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	54.66	6.85	7.08	0.59
liposarcoma cell line:KMLS-1	10782-110G8	51.71	6.40	3.12	1.09
liposarcoma cell line:SW 872	10726-110A6	60.07	5.24	6.94	1.10
liver, adult, pool1	10018-101C9	23.34	3.89	2.59	0.32
liver, fetal, pool1	10086-102B5	39.51	5.64	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	40.39	6.42	3.50	0.87
locus coeruleus, adult, donor10252	10165-103B3	75.11	6.09	4.80	0.74
locus coeruleus, adult, donor10258	10375-105G6	43.73	9.87	18.06	0.28
locus coeruleus, newborn, donor10223	10362-105F2	65.62	10.52	4.63	0.84
lung adenocarcinoma cell line:A549	10499-107C4	30.59	5.81	4.84	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	55.84	16.55	5.52	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	31.24	2.64	1.71	0.26
lung, adult, pool1	10019-101D1	37.21	5.43	3.90	1.06
lung, fetal, donor1	10068-101I5	139.56	19.41	6.28	2.00
lung, right lower lobe, adult, donor1	10075-102A3	65.07	11.91	5.96	1.37
lymph node, adult, donor1	10077-102A5	41.18	3.79	5.68	0.95
lymphangiectasia cell line:DS-1	10727-110A7	44.93	4.82	7.67	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	97.80	7.85	9.51	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	65.41	9.34	7.65	0.85
mature adipocyte, donor1	12231-129F8	47.51	6.66	6.22	0.89
mature adipocyte, donor2	12232-129F9	67.03	5.40	7.47	0.42
mature adipocyte, donor3	12233-129G1	54.05	4.74	0.95	0.47
mature adipocyte, donor4	12234-129G2	77.91	10.00	5.53	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	82.68	21.21	4.05	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	56.40	16.92	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	70.62	6.62	2.76	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	35.90	8.58	13.03	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	127.09	18.34	6.40	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	62.27	11.48	2.19	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	72.37	8.06	3.82	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	1.93	7.71	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	14.35	301.43	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	55.99	11.13	7.18	1.44
medulla oblongata - adult, donor10196	10174-103C3	51.92	7.14	4.54	0.65
medulla oblongata, adult, donor10252	10155-103A2	77.71	8.51	3.25	1.39
medulla oblongata, adult, pool1	10038-101F2	46.85	8.00	1.80	0.41
medulla oblongata, newborn, donor10223	10361-105F1	46.18	4.51	8.33	1.04
medulloblastoma cell line:D283 Med	10838-111E1	54.91	2.66	3.54	1.33
medulloblastoma cell line:ONS-76	10759-110E3	37.42	4.16	1.83	0.37
melanoma cell line:COLO 679	10514-107E1	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	39.09	5.16	3.53	0.00
meningioma cell line:HKBMM	10691-109F7	24.60	0.72	1.81	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	105.74	9.69	8.81	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	88.14	8.30	10.63	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.04	6.44	5.06	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.08	3.82	3.27	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	4.56	2.90	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.77	3.93	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.97	2.89	2.31	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	4.86	3.47	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.51	2.23	1.54	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.37	2.65	2.19	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	41.52	4.51	3.85	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	57.66	5.81	4.32	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	43.82	3.41	2.85	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.37	4.94	5.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	38.74	4.70	3.46	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	35.26	3.84	4.54	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.07	2.65	1.63	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	25.16	2.52	5.39	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.14	2.28	3.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.18	4.56	5.47	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.45	9.65	3.78	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.15	3.29	3.29	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	35.54	2.98	4.11	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.50	2.95	2.21	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	33.77	3.43	4.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.57	5.05	14.31	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.57	4.11	2.74	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.56	3.33	3.07	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.34	4.19	3.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.26	4.31	3.39	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	25.42	2.82	3.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.68	2.37	5.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.15	4.72	5.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	5.10	2.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	26.53	3.17	3.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.76	3.57	4.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.56	5.29	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.73	3.67	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.17	6.38	2.35	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	19.24	3.28	5.73	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.06	4.73	6.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	0.00	10.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	15.49	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.41	3.25	5.20	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	7.27	7.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.92	5.33	3.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	4.91	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.38	2.72	4.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	2.98	4.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.60	4.15	2.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	2.44	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.07	5.07	5.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.80	2.76	1.38	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.59	2.44	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	0.00	6.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.40	2.18	1.87	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	1.34	9.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	3.55	5.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	0.00	15.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	4.82	3.44	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	30.68	1.98	5.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	30.53	4.45	7.63	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	24.98	5.64	8.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	6.54	10.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	1.27	6.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	1.82	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	21.42	4.94	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.37	1.98	7.14	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.23	5.52	5.19	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	3.06	7.13	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	57.25	6.19	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	38.51	6.14	5.43	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	60.93	8.34	6.02	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	0.00	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.55	2.57	3.19	0.10
mesothelioma cell line:Mero-25	10850-111F4	21.79	2.27	2.72	0.00
mesothelioma cell line:Mero-41	10851-111F5	25.67	3.91	5.13	0.49
mesothelioma cell line:Mero-48a	10852-111F6	41.19	3.10	7.31	0.66
mesothelioma cell line:Mero-82	10853-111F7	48.88	2.37	16.56	1.31
mesothelioma cell line:Mero-83	10854-111F8	46.98	3.40	8.00	0.85
mesothelioma cell line:Mero-84	10855-111F9	19.46	1.01	4.04	0.00
mesothelioma cell line:Mero-95	10856-111G1	32.09	5.38	5.59	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	26.83	1.49	3.15	0.33
mesothelioma cell line:NCI-H226	10846-111E9	48.87	4.52	8.69	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	30.41	5.64	5.47	1.02
mesothelioma cell line:NCI-H28	10845-111E8	39.19	9.42	5.85	0.51
mesothelioma cell line:No36	10857-111G2	36.53	4.57	7.18	0.33
mesothelioma cell line:ONE58	10858-111G3	40.91	2.98	12.73	0.81
migratory langerhans cells, donor1	11901-125F2	60.84	7.48	2.11	0.96
migratory langerhans cells, donor2	11902-125F3	39.57	4.88	1.47	0.24
migratory langerhans cells, donor3	11903-125F4	58.69	7.72	2.33	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.69	0.33	4.57	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.27	1.06	6.99	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	45.84	5.30	2.30	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.63	7.99	5.90	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	98.68	8.69	9.98	0.55
myeloma cell line:PCM6	10474-106I6	25.30	5.14	5.14	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	50.73	1.52	7.10	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	48.64	4.12	3.33	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.94	2.12	5.46	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.78	2.87	6.40	0.29
nasal epithelial cells, donor2	12227-129F4	16.01	2.21	2.76	0.55
neuroblastoma cell line:CHP-134	10508-107D4	144.71	13.57	19.10	4.14
neuroblastoma cell line:NB-1	10539-107G8	90.92	17.21	15.72	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	121.68	5.48	9.49	1.05
neuroblastoma cell line:NH-12	10555-107I6	98.95	5.22	5.59	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	94.65	10.44	8.30	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	78.24	7.44	10.45	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	47.50	3.42	13.28	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	33.70	3.18	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	26.62	5.86	5.06	0.00
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	215.80	10.65	13.53	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	86.45	14.41	9.61	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.28	2.56	12.82	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	54.13	6.04	11.56	0.26
nucleus accumbens, adult, pool1	10037-101F1	51.46	11.90	2.44	0.09
occipital cortex - adult, donor10196	10172-103C1	74.17	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	79.70	8.32	7.78	0.81
occipital cortex, newborn, donor10223	10355-105E4	50.59	9.10	2.18	2.18
occipital lobe, adult, donor1	10076-102A4	56.42	8.92	6.30	0.52
occipital lobe, fetal, donor1	10073-102A1	135.60	21.46	17.59	2.15
occipital pole, adult, pool1	10036-101E9	24.05	6.78	0.87	0.16
olfactory region, adult	10195-103E6	35.92	6.88	2.48	0.57
optic nerve, donor1	10277-104E7	60.03	10.01	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.20	5.92	6.04	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	65.67	5.50	6.87	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	53.17	4.57	5.59	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	43.55	3.12	3.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	30.57	3.82	2.65	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	114.92	9.34	12.15	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	35.84	5.51	5.51	0.21
ovary, adult, pool1	10020-101D2	43.76	6.64	3.41	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.31	4.58	4.58	1.28
pancreas, adult, donor1	10049-101G4	50.79	4.70	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	38.02	1.68	6.99	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	52.64	3.92	6.30	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	94.05	4.80	5.63	1.49
paracentral gyrus, adult, pool1	10035-101E8	41.64	11.62	2.01	0.18
parietal cortex, adult, donor10258	10373-105G4	39.64	11.01	4.40	0.73
parietal lobe - adult, donor10196	10171-103B9	39.50	7.52	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	64.99	10.83	2.57	1.43
parietal lobe, adult, pool1	10034-101E7	41.33	10.49	2.64	0.18
parietal lobe, fetal, donor1	10072-101I9	114.44	27.16	16.49	1.94
parietal lobe, newborn, donor10223	10356-105E5	54.21	11.22	4.11	0.00
parotid gland, adult	10199-103F1	31.45	4.32	3.70	0.00
penis, adult	10200-103F2	49.95	8.06	6.45	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	51.69	7.62	4.28	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	51.28	5.39	6.99	0.58
pineal gland - adult, donor10196	10179-103C8	54.18	6.45	3.87	1.29
pineal gland, adult, donor10252	10160-103A7	133.84	10.66	6.51	2.96
pineal gland, adult, donor10258	10377-105G8	42.64	5.64	6.90	0.00
pituitary gland - adult, donor10196	10180-103C9	95.11	17.20	6.07	0.00
pituitary gland, adult, donor10252	10162-103A9	178.76	28.66	4.69	1.04
pituitary gland, adult, donor10258	10378-105G9	67.25	17.88	14.47	3.40
placenta, adult, pool1	10021-101D3	45.37	3.76	3.66	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	59.72	7.68	6.49	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	39.53	2.80	2.18	0.31
pons, adult, pool1	10033-101E6	42.26	10.50	2.84	0.17
postcentral gyrus, adult, pool1	10032-101E5	36.44	9.41	2.18	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	4.18	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	16.52	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	48.51	4.52	9.03	1.60
prostate cancer cell line:PC-3	10439-106E7	59.90	8.53	9.26	0.91
prostate, adult, pool1	10022-101D4	45.26	8.25	4.72	0.18
putamen, adult, donor10196	10176-103C5	64.68	15.34	2.60	0.47
putamen, adult, donor10252	10152-102I8	41.18	11.76	3.92	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	38.25	8.74	5.46	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	31.65	7.25	5.80	0.00
putamen, newborn, donor10223	10365-105F5	108.70	9.00	9.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	60.22	4.36	4.65	0.58
rectum, fetal, donor1	10067-101I4	79.29	11.13	6.95	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	44.94	7.21	2.33	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	33.55	5.38	9.94	2.90
retina, adult, pool1	10030-101E3	59.34	8.45	2.19	0.30
retinoblastoma cell line:Y79	10475-106I7	111.46	11.17	24.94	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	77.58	5.41	8.85	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	118.67	9.00	10.97	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	45.47	6.06	4.55	0.00
salivary acinar cells, donor1	11771-123I7	31.24	4.53	4.05	0.00
salivary acinar cells, donor2	11772-123I8	30.70	3.99	2.75	0.00
salivary acinar cells, donor3	11773-123I9	31.78	2.65	1.32	0.00
salivary gland, adult, pool1	10093-102C3	26.88	7.44	4.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.51	5.82	3.29	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	48.67	8.35	4.47	0.82
seminal vesicle, adult	10201-103F3	51.85	11.64	3.17	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.70	6.56	3.64	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	31.45	2.01	2.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	39.14	4.01	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	57.22	3.63	7.66	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	61.90	4.86	8.62	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	90.19	13.81	10.71	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	29.08	2.13	4.26	0.00
skeletal muscle, adult, pool1	10023-101D5	24.71	4.20	3.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	34.17	8.04	3.02	0.00
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	106.68	14.52	8.21	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	67.04	14.68	11.01	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	162.65	11.35	14.81	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	123.36	25.25	10.79	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	86.53	15.00	12.20	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	84.61	9.33	8.20	2.90
small cell lung carcinoma cell line:WA-hT	10562-108A4	77.14	4.36	5.88	2.62
small intestine, adult, pool1	10024-101D6	46.94	6.81	6.33	0.72
small intestine, fetal, donor1	10064-101I1	75.18	6.63	6.39	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	86.17	7.18	10.26	1.54
smooth muscle, adult, pool1	10048-101G3	62.29	5.17	1.55	1.03
somatostatinoma cell line:QGP-1	10781-110G7	59.23	10.45	3.48	0.27
spinal cord - adult, donor10196	10181-103D1	64.92	6.42	2.98	0.46
spinal cord, adult, donor10252	10159-103A6	83.98	7.89	3.55	0.79
spinal cord, adult, donor10258	10369-105F9	59.49	6.23	4.15	1.38
spinal cord, fetal, donor1	10056-101H2	87.82	7.32	9.76	2.44
spinal cord, newborn, donor10223	10359-105E8	83.12	7.81	6.89	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.34	4.63	2.99	0.00
spleen, adult, pool1	10025-101D7	38.00	6.94	3.52	0.33
spleen, fetal, pool1	10044-101F8	56.10	6.75	1.67	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	47.10	7.04	5.80	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	43.29	2.28	4.56	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	56.61	4.54	4.19	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.89	1.95	3.13	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	60.44	9.68	10.69	2.14
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	37.70	2.54	3.81	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	39.35	3.38	2.12	0.85
stomach, fetal, donor1	10062-101H8	85.44	8.54	7.48	1.07
submaxillary gland, adult	10202-103F4	48.42	6.84	5.70	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	217.10	162.82
substantia nigra, adult, donor10252	10158-103A5	90.98	8.52	6.23	1.66
substantia nigra, adult, donor10258	10371-105G2	38.28	6.72	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	45.22	7.07	4.95	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	99.04	15.59	19.95	1.60
temporal lobe, adult, pool1	10031-101E4	32.04	7.97	1.36	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	142.45	18.52	10.68	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	84.83	13.19	9.23	1.76
tenocyte, donor1	11763-123H8	31.42	4.89	3.84	0.00
tenocyte, donor2	11765-123I1	21.36	2.29	3.43	0.00
tenocyte, donor3	11768-123I4	30.77	2.59	8.53	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	68.15	6.97	7.99	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	66.44	2.16	8.63	1.23
teratocarcinoma cell line:PA-1	10807-111A6	58.74	4.34	6.04	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	57.25	5.84	6.47	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	60.13	3.78	3.78	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	53.88	7.42	3.60	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	44.30	12.70	7.82	0.00
testis, adult, pool1	10026-101D8	37.69	16.86	6.55	0.21
testis, adult, pool2	10096-102C6	56.84	37.89	5.86	0.45
thalamus - adult, donor10196	10168-103B6	71.76	7.73	5.52	0.00
thalamus, adult, donor10252	10154-103A1	101.74	8.44	4.84	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	6.16	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.80	4.94	10.87	0.99
thalamus, newborn, donor10223	10366-105F6	43.15	8.05	6.33	0.58
throat, adult	10209-103G2	58.67	8.49	3.75	0.25
throat, fetal, donor1	10061-101H7	89.28	11.88	14.63	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	89.63	6.56	14.90	1.39
thymus, adult, pool1	10027-101D9	78.34	6.46	3.58	0.40
thymus, fetal, pool1	10043-101F7	158.25	10.18	5.30	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	41.22	3.59	7.45	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	35.20	3.49	4.75	1.12
thyroid, adult, pool1	10028-101E1	52.54	9.33	5.04	0.37
thyroid, fetal, donor1	10060-101H6	81.21	13.71	7.65	4.22
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	9.24	6.16	3.08
tongue, adult	10203-103F5	34.65	5.81	3.26	0.00
tongue, fetal, donor1	10059-101H5	54.38	7.88	6.31	0.79
tonsil, adult, pool1	10047-101G2	55.90	8.21	3.41	0.40
trachea, adult, pool1	10029-101E2	43.03	5.32	2.21	0.25
trachea, fetal, donor1	10058-101H4	61.17	6.16	5.00	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.59	4.96	6.73	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	127.56	12.97	9.32	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	60.95	8.46	10.50	0.94
tridermal teratoma cell line:HGRT	10694-109G1	53.27	3.81	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.42	4.15	2.45	0.59
umbilical cord, fetal, donor1	10057-101H3	45.90	6.26	8.35	0.00
uterus, adult, pool1	10100-102D1	67.40	10.92	3.24	1.37
uterus, fetal, donor1	10055-101H1	93.17	10.75	9.21	2.56
vagina, adult	10204-103F6	54.93	7.11	1.29	0.00
vein, adult	10191-103E2	45.81	7.23	3.29	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	43.53	3.47	5.87	0.53